×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
合肥物质科学研究院 [9]
内容类型
期刊论文 [9]
发表日期
2022 [5]
2021 [2]
2020 [2]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共9条,第1-9条
帮助
限定条件
内容类型:期刊论文
专题:合肥物质科学研究院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study
期刊论文
EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174
作者:
Wang, Wenxian
;
Lin, Gen
;
Guan, Yelan
;
Zhang, Yuxin
;
Xu, Chunwei
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2022/12/23
Thymic carcinoma
Immunotherapy
PD-1
Efficacy
Immune-related adverse events
Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial
期刊论文
BMC MEDICINE, 2022, 卷号: 20
作者:
Song, Zhengbo
;
Lou, Guangyuan
;
Wang, Yina
;
Yang, Zhiping
;
Wang, Wenxian
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2022/12/23
Thymic epithelial tumors
Apatinib
Efficacy
Toxicities
Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study
期刊论文
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:
Wang, Wenxian
;
Shao, Lan
;
Xu, Yibing
;
Song, Zhengbo
;
Lou, Guangyuan
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2022/12/23
Non-small cell lung cancer
Prognosis
Angiogenesis
Tyrosine kinase inhibitors
Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report
期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 卷号: 11
作者:
Gu, Xiaodong
;
Wang, Wenxian
;
Wu, Wei
;
Zhang, Yiping
;
Shao, Lan
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2022/12/22
Non-small cell lung cancer (NSCLC)
HIVEP1-ALK
alectinib
intergenic region (IGR)
case report
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study
期刊论文
GENES CHROMOSOMES & CANCER, 2022
作者:
Wang, Wenxian
;
Gu, Xiaodong
;
Si, Jinfei
;
Pu, Xingxiang
;
Wang, Liping
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2022/05/16
BRAF mutation
immune checkpoint inhibitors
non-small cell lung cancer
PD-L1
targeted therapy
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China
期刊论文
THORACIC CANCER, 2021
作者:
Shi, Yuequan
;
Fang, Jian
;
Zhou, Chengzhi
;
Liu, Anwen
;
Wang, Yan
收藏
  |  
浏览/下载:65/0
  |  
提交时间:2022/01/25
advanced lung cancer
immune checkpoint inhibitors
immune-related adverse events
real-world data
The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study
期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:
Wang, Wenxian
;
Gu, Xiaodong
;
Wang, Liping
;
Pu, Xingxiang
;
Feng, Huijing
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2022/01/10
Non-small cell lung cancer
PD-L1
Immune checkpoint inhibitor
Immune-related adverse event
Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer
期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:
Wang, Wenxian
;
Huang, Zhangzhou
;
Yu, Zongyang
;
Zhuang, Wu
;
Zheng, Weijun
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2020/11/30
immune checkpoint inhibitor
non-small cell lung cancer
biomarker
chemotherapy
lung immune prognostic index
Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation
期刊论文
ONCOGENE, 2020, 卷号: 39
作者:
Jin, Ying
;
Bao, Hua
;
Le, Xiuning
;
Fan, Xiaojun
;
Tang, Ming
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2020/11/26
©版权所有 ©2017 CSpace - Powered by
CSpace